Price: $0.1962
$-0.02
-10.818%
|
Day's High:
| $0.24
| Week Perf:
| -29.17 %
|
Day's Low: |
$ 0.20 |
30 Day Perf: |
-22.91 % |
Volume (M): |
1,607 |
52 Wk High: |
$ 2.28 |
Volume (M$): |
$ 315 |
52 Wk Avg: |
$0.54 |
Open: |
$0.24 |
52 Wk Low: |
$0.16 |
|
|
Market Capitalization (Millions $) |
30 |
Shares
Outstanding (Millions) |
153 |
Employees |
51 |
Revenues (TTM) (Millions $) |
71 |
Net Income (TTM) (Millions $) |
-373 |
Cash Flow (TTM) (Millions $) |
-161 |
Capital Exp. (TTM) (Millions $) |
20 |
Cue Health Inc
Cue Health Inc. is a healthcare technology company that provides a range of diagnostic products and services to individuals and healthcare providers. The company's primary focus is on the development and commercialization of portable, easy-to-use diagnostic devices that allow individuals to monitor their health at home or in other settings. Cue Health's flagship product is a compact, battery-powered device called the Cue Health Monitoring System, which uses a small cartridge to conduct a range of diagnostic tests, from measuring biomarkers such as vitamin D levels to detecting influenza and COVID-19. The system is designed to provide accurate results within minutes and can be connected to a mobile app that allows individuals to track their health over time. The company also offers a COVID-19 testing service in partnership with healthcare providers and employers, using the Cue Health Monitoring System to conduct rapid tests in a variety of settings, from schools and sporting events to airports and workplaces. The service aims to help identify and isolate individuals who may be infected with the virus, as well as to provide employers with insights into the health of their workforce. Cue Health was founded in 2010 by a team of scientists, engineers, and entrepreneurs with the goal of making healthcare more accessible and convenient for individuals. The company is headquartered in San Diego, California, and has raised over $230 million in funding from investors including Johnson & Johnson and Decheng Capital.
Company Address: 4980 Carroll Canyon Rd San Diego 92121 CA
Company Phone Number: 412-8151 Stock Exchange / Ticker: NASDAQ HLTH
|
|
|
|
|
Stock Performances by Major Competitors |
|
|
Cue Health Inc
The Laboratory Analytical Instruments company recently announced its financial results for the fiscal year ending December 31, 2023. The report highlighted a significant decline in revenue and a widening shortfall per share compared to the previous reporting season. Additionally, Cue Health Inc, a related company, also reported a substantial net loss and a decrease in inventories. These financial figures provide insights into the company's performance and potential future challenges. Financial Results: The Laboratory Analytical Instruments company's revenue for the period ending December 31, 2023, plunged by a staggering 87.193% to $18.80 million. This decline was accompanied by a significant increase in the shortfall per share, which reached $-0.93 compared to $-0.31 in the previous reporting season. While the sequential revenue growth of 7.559% from $17.48 million offers some optimism, the overall financial results are concerning.
|
Cue Health Inc
Cue Health Inc, a Laboratory Analytical Instruments company, has reported its financial results for the July to September 30, 2023, time frame. The company has shown some improvements in its financial performance compared to the previous year. In terms of earnings per share, Cue Health Inc managed to decrease its loss per share from $-0.45 to $-0.31. This is a positive sign for the company as it indicates that they have been able to reduce their losses. Additionally, the company's income per share improved from $-0.55 to an undisclosed value, which suggests that Cue Health Inc has been able to generate more income.
|
Cue Health Inc
As a stock market journalist, it is crucial to analyze and interpret the financial results of companies accurately. Today, we will delve into Cue Health Inc's latest financials. Starting with the fiscal period closing June 30, 2023, Cue Health Inc managed to decrease its loss per share from $-0.67 to $-0.55 compared to the previous year. This is a positive sign, indicating possible improvements in the company's financial health. Additionally, their income per share also showed improvement, moving from $-0.62 per share in the previous reporting period.
|
Cue Health Inc
The world of investing can be a rollercoaster ride, and often even the best of companies can experience a period of turbulence. Recently, the Biotechnology & Pharmaceuticals company, Cue Health Inc, disclosed a disappointing financial first quarter of 2023. However, even amidst this challenging time, there are still reasons to remain optimistic about the stock market as a whole. It's important to acknowledge that Cue Health Inc's financial results were certainly poor, with a declining revenue and a net deficit per share that ballooned from the previous year. However, in the often-volatile world of biotech and pharmaceuticals, it's not uncommon to encounter setbacks along the way. Instead of panicking, investors should take a step back and consider the bigger picture. One of the keys to successful investing is to focus on the long term, rather than short term results. Despite the disappointing Q1 results, Cue Health Inc has a promising portfolio of products and services that could lead to future success. Furthermore, with a new financial reporting period beginning, there is always the chance for the company to turn things around and begin to see growth again.
|
Per Share |
Current |
Earnings (TTM) |
-2.41 $ |
Revenues (TTM) |
0.46 $
|
Cash Flow (TTM) |
- |
Cash |
0.53 $
|
Book Value |
1.64 $
|
Dividend (TTM) |
0 $ |
|
Per Share |
|
Earnings (TTM) |
-2.41 $
|
Revenues (TTM) |
0.46 $ |
Cash Flow (TTM) |
- |
Cash |
0.53 $
|
Book Value |
1.64 $ |
Dividend (TTM) |
0 $ |
|
|
|
|